Mowat-Wilson Syndrome (MWS) is a rare autosomal dominant disorder that is characterized by distinct facial appearance, intellectual disability, and other congenital malformations. While the syndrome may not be prevalent, prompt diagnosis with precision is essential to obtain proper medical care and developmental therapy.
Nonetheless, due to its rarity and overlap with other diseases, it can be challenging to diagnose MWS solely with simple tests. Let’s learn how the diagnostic process for MWS typically unfolds.
Mowat-Wilson Syndrome results from mutations or deletions of the ZEB2 gene (originally designated as ZFHX1 B) at locus 2q22. The gene encodes for a protein that is crucial in the development of numerous body systems, among them being the nervous, digestive, and facial structures.
The majority of cases of MWS are caused by new (de novo) mutations, and therefore, they occur singly without being passed down from parents. In extremely rare instances, though, the condition is hereditary in an autosomal dominant manner if one of the parents has the mutation.
MWS is usually suspected in infancy or early childhood when some of the physical characteristics and delayed development become apparent. Some of the initial indications that need to be investigated are:
If a pediatrician identifies several such signs, they can refer the child to a geneticist for further medical evaluation.
Diagnosis of MWS is established mainly through genetic testing, which identifies mutations in the gene ZEB2, responsible for the syndrome. The following are primarily used:
All of these tests may be done on blood or saliva specimens and are interpreted by trained and certified genetic professionals.
Mowat-Wilson Syndrome is typically diagnosed in infancy (6–12 months) when hallmark facial features (e.g., hypertelorism, pointed chin) and developmental delays become apparent. In cases with milder symptoms or where access to genetic testing is delayed, diagnosis may occur later.
Yes, in certain situations, prenatal diagnosis can be achieved to detect Mowat-Wilson Syndrome. If there is a family history of MWS or if ultrasound during pregnancy is abnormal, physicians may advise other genetic testing, like:
These procedures can enable the testing of fetal DNA to detect mutations of the ZEB2 gene. As the condition is rare, routine prenatal screening for MWS is not generally done.
Early diagnosis paves the way to a multidisciplinary care approach, which can greatly enhance quality of life. A few of the timely interventions are:
A confirmed diagnosis also gives parents clear information about long-term prognosis and the availability of genetic counseling for future pregnancies.
The expense of specialist consultation and genetic tests may be staggering. Fortunately, many comprehensive health insurance plans, including those from Star Health Insurance, may cover these treatment costs and diagnostic tests under the terms of the policy.
Star Health Insurance provides policies to treat congenital disorders and pays for hospitalization, therapies, and consultation. It's advisable to review your policy or speak with an insurance advisor to understand the scope of coverage.
If you are in doubt that your child has MWS, refer to your pediatrician and ask them to refer you to a clinical geneticist. A detailed developmental history, symptoms, and family history are helpful to make an early clinical impression.
In addition, you may also refer to support groups for rare diseases to offer emotional support and access to resources that can aid your child’s development.
An accurate diagnosis of Mowat-Wilson Syndrome is based on clinical assessment and genetic analysis. Early symptoms can arouse suspicion but need to be confirmed with specific testing for the ZEB2 gene.
With early intervention and access to proper medical facilities, some of which may be included in well-planned healthcare policies like those offered by Star Health Insurance, such affected children can receive the support they need for better developmental outcomes.